Access
To read this story in full you will need to login or make a payment (see right).
News
Nature 404, 319-320 (23 March 2000) | doi:10.1038/35006215
Open Innovation Challenges
-
Direct Molecular Detection of Proteins and Nucleic Acids
This Challenge is looking for novel approaches to protein and nucleic acid detection. This is an Id...
-
Single-cell Analysis Platform
This Challenge is looking for novel approaches to analyzing changes at a single-cell level. This is...
- More Challenges
- Powered by:
nature jobs
Senior DMPK scientist
- Cancer Research Technology (CRT)
- London, United Kingdom
International PhD Programme
- MRC Laboratory of Molecular Biology
- Cambridge, UK
Researchers caught in dispute over transgenic mice patents
See associated Correspondence: Younkin & Stoddard, Nature 404, 809 (April 2000)
Rex Dalton
Neuroscientists who use mouse models are closely watching a patent infringement battle between a prominent biotechnology firm and a major US non-profit institution. Elan Pharmaceuticals, of Ireland, is suing the Minnesota-based Mayo Foundation for Medical Education and Research over mice used to study Alzheimer's disease.
To read this story in full you will need to login or make a payment (see right).
